ArticleCancer2013

Carbohydrate antigen 19-9 is a prognostic and predictive biomarker in patients with advanced pancreatic cancer who receive gemcitabine-containing chemotherapy: a pooled analysis of 6 prospective trials.

Todd M Bauer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.